SC 13D

Company

Cresco Labs Inc.

Filed

February 16, 2024

Accession Number

0001832928-24-000017

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →